Women have a clinical advantage over men regarding atherosclerotic cardiovascular disease risk, which disappears by their seventh decade when risk equals that of men.
This review discusses the mechanisms, including hormonal, morphological, and physiological differences, underlying the gender differences in vascular aging and coronary artery disease pathophysiology.
Women have a clinical advantage over men in relation to atherosclerotic cardiovascular disease (CVD) (morbidity and mortality). This advantage disappears once women become older, and in their seventh decade, the risk to develop CVD equals men at that age. There have been several theories about this gender difference that were related to hormones, and the different morphology and physiology that characterize the cardiovascular system in women. In this review, the different mechanisms will be reviewed and discussed.
Arnon Blum (Thu,) conducted a review in Atherosclerotic cardiovascular disease (CVD). Women have a clinical advantage over men regarding atherosclerotic cardiovascular disease risk, which disappears by their seventh decade when risk equals that of men.